At AUA 2018 today, Dornier MedTech announced the launch of Dornier Delta® III SmartLitho™, which offers an analytic algorithm to help urologists make treatment decisions. The new Dornier Delta® III SmartLitho™ can utilize Dornier’s proprietary analytic algorithm, which is able to provide real world data from extracorporeal shock wave lithotripsy (ESWL) treatments of urological stones by validating against a broad set of data points collected globally. The novel algorithm enables urologists to make personalized, evidence-based decisions by assessing historical success rates of treatment modalities as well as identify and balance costs.
We can’t wait to share about our products with you! Product and brochure availability may vary between countries, but we’ll be in touch.
Fill out the form below to receive the download link.